Stifel downgrades Biogen on slow Alzheimer’s drug launch, uncertainty ahead
Go back to Stifel downgrades Biogen on slow Alzheimer’s drug launch, uncertainty ahead| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 224.51 +1.84 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $222.67 | 52 Week High | $333.65 | |||
| Open | $225.44 | 52 Week Low | $223.02 | |||
| Day High | $225.80 | P/E | 28.75 | |||
| Day Low | $221.23 | EPS | $7.81 | |||
| Volume | 550,713 | |||||
